|
B.C. has approved funding for a drug that can significantly slow the physical decline associated with ALS, also known as Lou Gehrig’s disease. Health Minister Adrian Dix said the province will cover the cost of edaravone, which goes by the brand name Radicava, starting Aug. 19. An estimated 66 to 183 people in B.C. with amyotrophic lateral sclerosis, or ALS, will benefit from the coverage, he said.
|